COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,093 Articles (22,658 medRxiv, 8,435 bioRxiv)

Most recent first Previous |  Page 283: Articles 2821-2830  | Next

The association between SARS-CoV-2 infections in English primary and secondary school children and staff, and infections in members of their household in the schoolyear 2020-2021: a self-controlled case-series analysis
McClenaghan, E., Nguipdop-Djomo, P., Lewin, A., Warren-Gash, C., Cook, S., Mangtani, P.
10.1101/2023.11.27.23299066 — Posted: 2023-11-27
Correlation between Galanin and its receptor with the serum electrolytes in Long-COVID patients
Al-Masoodi, W. T. M., Radhi, S. W., Abdalsada, H. K., Al-Hakeim, H. K.
10.1101/2023.11.27.23299076 — Posted: 2023-11-27
Dissecting Clinical Features of COVID-19 in a Cohort of 21,312 Acute Care Patients
Maguire, C., Soloveichik, E., Blinchevsky, N., Miller, J., Morrison, R., Busch, J., Brode, W. M., Wylie, D., Rousseau, J., Melamed, E.
10.1101/2023.11.27.23297171 — Posted: 2023-11-27
Planning for the End at the Beginning: A Lesson in Sharing Research Findings of a Community-based COVID-19 Seroprevalence Survey
Trolard, A., Hickner, E., Anwuri, V., Johnson, K., Goss, C., Cohen, R., Donaldson, K., Geng, E., Maricque, B.
10.1101/2023.11.27.22273609 — Posted: 2023-11-27
Antibiotic Utilisation Patterns in Tanzania: A Retrospective Longitudinal Study Comparing Pre- and Post-COVID-19 Pandemic Using Tanzania Medicines and Medical Devices Authority Data
Sangeda, R. Z., William, S. M., Masatu, F. C., Bitegeko, A., Mwalwisi, Y. H., Nkiligi, E. A., Horumpende, P. G., Fimbo, A. M.
10.1101/2023.11.27.23299060 — Posted: 2023-11-27
Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains
Bouzidi, H. S., Driouich, J.-S., Klitting, R., Bernadin, O., Piorkowski, G., Amaral, R., Fraisse, L., Mowbray, C. E., Scandale, I., Escudie, F., Chatelain, E., de Lamballerie, X., Nougairede, A., Touret, F.
10.1101/2023.11.22.568013 — Posted: 2023-11-27
XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against emerging SARS-CoV-2 variants
Wang, Q., Guo, Y., Bowen, A., Mellis, I. A., Valdez, R., Gherasim, C., Gordon, A., Liu, L., Ho, D. D.
10.1101/2023.11.26.568730 — Posted: 2023-11-27
Early warning system using primary healthcare data in the post-COVID-19-pandemic era: Brazil nationwide case-study
Cerqueira-Silva, T., Oliveira, J. F., Oliveira, V. d. A., Florentino, P. T. V., Sironi, A., Penna, G. O., Pereira Ramos, P. I., Boaventura, V. S., Barral-Netto, M., Marcilio, I.
10.1101/2023.11.24.23299005 — Posted: 2023-11-27
Characteristics of SARS-CoV-2 reinfection with Omicron BA.2.75 subvariants in Thai Adults.
Assawakosri, S., Sudhinaraset, N., Chansaenroj, J., Suntronwong, N., Kanokudom, S., Nalinpakorn, N., Tantipraphat, N., Sethabutra, A., Honsawek, S., Poovorawan, Y.
10.1101/2023.11.24.23298841 — Posted: 2023-11-27
SARS-CoV-2 sequencing with cloud-based analysis illustrates expedient co-ordinated surveillance of viral genomic epidemiology across six continents
Amoako, D., Anh, N. T., Brouard, M., Campano Romero, C., Castillo Ramirez, A., Constantinides, B., Crook, D., Cuong, P. M., Diagne, M. M., Diallo, A., Dung, N. T., Dunn, L., Duyet, L. V., Everatt, J., Fletcher, K., Fowler, P., Gail, M., Hospital for Tropical Diseases SARS-CoV-2 testing team, , Hong, N. T. T., Hunt, M., Iqbal, Z., Jeffery, K., Kekana, D., Kesteman, T., Knaggs, J., Lopes Alves, M., Man, D. N. H., Mathers, A., Ngoc, N. M., Oakley, S., Parikh, H., Peto, T., Rojas Herrera, M., Sanderson, N., Sintchenko, V., Swann, J., Tam, N. T., Tan, L. V., Thach, P. N., Top, N. M., Trang, N. T.
10.1101/2023.11.27.23298986 — Posted: 2023-11-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).